BAM
IBB icon

Byrne Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Byrne Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$318K Sell
1,674
-32
-2% -$5.5K 0.17% 99
2026
Q1 		$288K Sell
1,706
-107
-6% -$18.3K 0.17% 101
2025
Q4 		$306K Buy
1,813
+1,274
+236% +$207K 0.17% 101
2025
Q3 		$77.8K Sell
539
-4
-0.7% -$546 0.05% 180
2025
Q2 		$68.7K Sell
543
-10
-2% -$1.23K 0.05% 185
2025
Q1 		$70.7K Buy
+553
New +$75K 0.05% 173
2024
Q4 		– Sell
-852
Closed -$120K – 159
2024
Q3 		$124K Sell
852
-32
-4% -$4.63K 0.08% 139
2024
Q2 		$122K Sell
884
-595
-40% -$79.4K 0.09% 140
2024
Q1 		$203K Buy
+1,479
New +$202K 0.14% 105
2023
Q4 		– Sell
-1,556
Closed -$190K – 110
2023
Q3 		$190K Hold
1,556
– – 0.16% 108
2023
Q2 		$198K Buy
1,556
+4
+0.3% +$520 0.13% 145
2023
Q1 		$200K Sell
1,552
-52
-3% -$6.81K 0.14% 130
2022
Q4 		$211K Buy
1,604
+805
+101% +$104K 0.15% 128
2022
Q3 		$93K Hold
799
– – 0.07% 163
2022
Q2 		$94K Sell
799
-233
-23% -$27.7K 0.07% 146
2022
Q1 		$134K Sell
1,032
-49
-5% -$6.38K 0.08% 139
2021
Q4 		$165K Buy
+1,081
New +$167K 0.11% 122

Other funds holding IBB

GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
FNFDCM
Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
RFA
Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SCA
Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

Byrne Asset Management's IBB Position: Q2 2026 in Review

Byrne Asset Management reduced its iShares Biotechnology ETF (IBB) stake by 1.9% in Q2 2026, selling an estimated $5.5K and leaving 1,674 shares worth $318K. The position accounts for 0.17% of the portfolio, ranked #99.

Byrne Asset Management first reported a position in IBB in Q4 2021 and has held it in 17 quarters since. 158 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Byrne Asset Management held 1,674 shares of iShares Biotechnology ETF worth $318K as of Q2 2026.
  • Byrne Asset Management sold 32 iShares Biotechnology ETF shares in Q2 2026, an estimated $5.5K.
  • iShares Biotechnology ETF made up 0.17% of Byrne Asset Management's portfolio in Q2 2026, its #99 holding.
  • Byrne Asset Management first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 17 quarters since.
  • 158 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.